Navigation Bordeaux Population Health Research Center (BPH) - UMR 1219 par Auteur "NACHBAUR, G."
-
Demandes d'études post-inscription (EPI), suivi des patients en vie réelle : évolution de la place des bases de données
BERDAI, Driss; THOMAS-DELECOURT, F.; SZWARCENSZTEIN, K. ...(Thérapie. vol. 73, n° 1, pp. 1-12, 2018-02)Article de revue -
Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databases
BERDAI, Driss; THOMAS-DELECOURT, F.; SZWARCENSZTEIN, K. ...(Thérapie. vol. 73, n° 1, pp. 13-24, 2018-02)Article de revue -
Costs associated with hospitalization in HIV-positive patients in France
DE LEOTOING, L.; YAZDANPANAH, Y.; FINKIELSZTEJN, L. ...(AIDS. Official journal of the international AIDS Society. vol. 32, n° 14, pp. 2059-2066, 2018-09-10)Article de revue -
Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic Review
ARLEGUI, Hugo; NACHBAUR, G.; PRAET, N. ...(Open Forum Infectious Diseases. vol. 7, n° 4, pp. ofaa087, 2020)Article de revueLibre accès -
Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to Vaccines
ARLEGUI, Hugo; BOLLAERTS, K.; SALVO, Francesco...
(Drug Safety. vol. 43, n° 11, pp. 1089-1104, 2020)Article de revueLibre accès -
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)
ARLEGUI, Hugo; BOLLAERTS, K.; BAUCHAU, V. ...(Drug Safety. vol. 43, n° 11, pp. 1105-1120, 2020)Article de revueLibre accès -
Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit-Risk Models: The Example of Rotavirus Vaccination in France
ARLEGUI, Hugo; NACHBAUR, G.; PRAET, N. ...(Clinical Therapeutics. vol. 42, n° 10, pp. 1983-1991 e2, 2020)Article de revueLibre accès